Danish Mask Study, Rivaroxaban for Atrial Fibrillation and Bioprosthetic Mitral Valve, Convalescent Plasma Fails, Semaglutide in NASH, Once Weekly Insulin, Statin Nocebo Effect
HomeLast Week in Medicine › Episode

Danish Mask Study, Rivaroxaban for Atrial Fibrillation and Bioprosthetic Mitral Valve, Convalescent Plasma Fails, Semaglutide in NASH, Once Weekly Insulin, Statin Nocebo Effect

38:11 Dec 3, 2020
About this episode
We're back with our second episode of the new season.  Dr. Rupp is sporting a new mustache, and we discuss the mysterious monolith discovered in the Utah desert.  If you want to skip the banter, go to 6:56. This week we try to figure out what that Danish Mask Study really showed.  Is it safe to use rivaroxaban in patients with a bioprosthetic mitral valve and A fib?  Does convalescent plasma improve outcomes in COVID-19?   Danish Mask StudyCDC Report on Kansas Mask MandatesRivaroxaban for A fib and Bioprosthetic Mitral ValveConvalescent Plasma for COVID-19Semaglutide and NASHWeekly Icodec InsulinStatin Nocebo EffectMusic from https://filmmusic.io"Sneaky Snitch" by Kevin MacLeod (https://incompetech.com)License: CC BY (http://creativecommons.org/licenses/by/4.0/)Music from Uppbeat (free for Creators!): https://uppbeat.io/t/soundroll/dope License code: NP8HLP5WKGKXFW2R
Select an episode
0:00 0:00